4.8 Article

GSK-3α/β Activity Negatively Regulates MMP-1/9 Expression to Suppress Mycobacterium tuberculosis Infection

Journal

FRONTIERS IN IMMUNOLOGY
Volume 12, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2021.752466

Keywords

Mycobacteria tuberculosis; macrophages; GSK-3a/beta; MMP-1; MMP-9

Categories

Funding

  1. National Natural Science Foundation of China [81772150, 82072242, 82070010, 81801584, 81800013]
  2. Guangdong Basic and Applied Basic Research Foundation [2021A1515010933, 2019A 1515010988, 2018030310486]

Ask authors/readers for more resources

This study reveals the significant role of GSK-3alpha/beta pathway in regulating immune response of macrophages to Mycobacterium tuberculosis infection. It also demonstrates that PKC-delta and mTOR can influence the activation of GSK-3alpha/beta and subsequently regulate the expression of MMP-1/9. These findings provide new insights into the immune escape mechanism of tuberculosis and the crosstalk between critical signaling pathways.
Tuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb) infection is the deadliest infectious disease and a global health problem. Macrophages (M phi s) and neutrophils that can phagocytose Mtb represent the first line of immune response to infection. Glycogen synthase kinase-3 alpha/beta (GSK-3 alpha/beta) represents a regulatory switch in host immune responses. However, the efficacy and molecular mechanisms of how GSK-3 alpha/beta interacts with Mtb infection in M phi s remain undefined. Here, we demonstrated that Mtb infection downregulated GSK-3 alpha/beta activity and promoted matrix metalloproteinase-1 (MMP-1) and MMP-9 expressions in M phi s derived from acute monocytic human leukemia THP-1 cells (THP-1-M phi s). We confirmed the upregulation of MMP-9 expression in tissues of TB patients compared with patients of chronic inflammation (CI). In THP-1-M phi s and C57BL/6 mice, GSK-3 alpha/beta inhibitor SB216763 significantly increased MMP-1/9 production and facilitated Mtb load, while MMP inhibitors blocked MMP-1/9 expression and Mtb infection. Consistently, GSK-3 alpha/beta silencing significantly increased MMP-1/9 expression and Mtb infection, while overexpression of GSK-3 alpha/beta and constitutive activated GSK-3 alpha/beta mutants significantly reduced MMP-1/9 expression and Mtb infection in THP-1-M phi s. MMP-1/9 silencing reduced Mtb infection, while overexpression of MMP-1/9 promoted Mtb infection in THP-1-M phi s. We further found that GSK-3 alpha/beta inhibition increased Mtb infection and MMP-1/9 expression was blocked by ERK1/2 inhibitor. Additionally, we showed that protein kinase C-delta (PKC-delta) and mammalian target of rapamycin (mTOR) reduced GSK-3 alpha/beta activity and promoted MMP-1/9 production in Mtb-infected THP-1-M phi s. In conclusion, this study suggests that PKC-delta-mTOR axis suppresses GSK-3 alpha/beta activation with acceleration of MMP-1/9 expression through phospho-ERK1/2. These results reveal a novel immune escape mechanism of Mtb and a novel crosstalk between these critical signaling pathways in anti-TB immunity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available